Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Zomedica Corp (AMEX: ZOM) closed the day trading at $0.14 down -0.35% from the previous closing price of $0.14. In other words, the price has decreased by -$0.35 from its previous closing price. On the day, 3.37 million shares were traded. ZOM stock price reached its highest trading level at $0.1431 during the session, while it also had its lowest trading level at $0.1372.
Ratios:
For a better understanding of ZOM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.49 and its Current Ratio is at 11.06. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Dawson James on January 06, 2023, initiated with a Buy rating and assigned the stock a target price of $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 15 ’23 when POWERS JOHNNY D bought 100,000 shares for $0.17 per share. The transaction valued at 16,500 led to the insider holds 1,950 shares of the business.
POWERS JOHNNY D bought 100,000 shares of ZOM for $16,600 on Nov 17 ’23. The Director now owns 1,850,000 shares after completing the transaction at $0.17 per share. On Nov 17 ’23, another insider, HEATON LARRY C II, who serves as the CEO of the company, bought 100,000 shares for $0.17 each. As a result, the insider paid 16,600 and bolstered with 200,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZOM now has a Market Capitalization of 138760928 and an Enterprise Value of 50993872. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.51 while its Price-to-Book (P/B) ratio in mrq is 0.58. Its current Enterprise Value per Revenue stands at 2.025 whereas that against EBITDA is -2.016.
Stock Price History:
Over the past 52 weeks, ZOM has reached a high of $0.25, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is 4.61%, while the 200-Day Moving Average is calculated to be -13.93%.
Shares Statistics:
Over the past 3-months, ZOM traded about 4.84M shares per day on average, while over the past 10 days, ZOM traded about 4348880 shares per day. A total of 979.95M shares are outstanding, with a floating share count of 964.36M. Insiders hold about 1.59% of the company’s shares, while institutions hold 8.84% stake in the company. Shares short for ZOM as of 1713139200 were 60717146 with a Short Ratio of 12.56, compared to 1710460800 on 57823014. Therefore, it implies a Short% of Shares Outstanding of 60717146 and a Short% of Float of 6.3.
